SCHEMBL29430079

SCHEMBL29430079

N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ MEN1 O00255 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ MPO P05164 1/20 0.58
▸ MAPT P10636 1/20 0.58
▸ TSHR P16473 1/20 0.58
▸ BLM P54132 1/20 0.58
▸ PMP22 Q01453 1/20 0.58
▸ HIF1A Q16665 1/20 0.58
▸ MME P08473 1/20 0.56
▸ OPRM1 P35372 1/20 0.56
▸ OPRD1 P41143 1/20 0.56
▸ ACE P12821 1/20 0.54
▸ GHSR Q92847 1/20 0.54
▸ ERAP2 Q6P179 1/20 0.54
▸ CCKBR P32239 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31485773 0.97 LTA4H (0.62) LTA4HKMT2AKDM4EMEN1LMNA
SCHEMBL29828595 0.97 LTA4H (0.62) LTA4HKMT2AKDM4EMEN1LMNA
SCHEMBL29440485 0.95 KDM4E (0.64) LTA4HKMT2AKDM4EMEN1LMNA
SCHEMBL29828625 0.95 KDM4E (0.64) LTA4HKMT2AKDM4EMEN1LMNA
SCHEMBL29828268 0.95 KDM4E (0.64) LTA4HKMT2AKDM4EMEN1LMNA
SCHEMBL29829233 0.95 KDM4E (0.64) LTA4HKMT2AKDM4EMEN1LMNA
SCHEMBL29828893 0.95 KDM4E (0.64) LTA4HKMT2AKDM4EMEN1LMNA
SCHEMBL29828703 0.95 KDM4E (0.64) LTA4HKMT2AKDM4EMEN1LMNA
SCHEMBL29828853 0.95 KDM4E (0.64) LTA4HKMT2AKDM4EMEN1LMNA
SCHEMBL29828574 0.95 KDM4E (0.64) LTA4HKMT2AKDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204092-A1 MULTI-SPECIFIC ANTIGEN BINDING MOLECULES TARGETING HIV AND METHODS OF USE GILEAD SCIENCES, INC. (US) 2023-07-05 — — EP claimed
WO-2022046644-A1 MULTI-SPECIFIC ANTIGEN BINDING MOLECULES TARGETING HIV AND METHODS OF USE GILEAD SCIENCES, INC. (US) 2022-03-03 — — WO claimed
US-20250059261-A1 MULTI-SPECIFIC ANTIGEN BINDING MOLECULES TARGETING HIV AND METHODS OF USE GILEAD SCIENCES, INC. 2025-02-20 — — US disclosed
US-12195524-B2 Multi-specific antigen binding molecules targeting HIV and methods of use GILEAD SCIENCES, INC. (US) 2025-01-14 — — US disclosed
EP-4204092-A1 MULTI-SPECIFIC ANTIGEN BINDING MOLECULES TARGETING HIV AND METHODS OF USE GILEAD SCIENCES, INC. (US) 2023-07-05 — — EP disclosed
US-20230056252-A1 MULTI-SPECIFIC ANTIGEN BINDING MOLECULES TARGETING HIV AND METHODS OF USE GILEAD SCIENCES, INC. 2023-02-23 — — US disclosed
WO-2022046644-A1 MULTI-SPECIFIC ANTIGEN BINDING MOLECULES TARGETING HIV AND METHODS OF USE GILEAD SCIENCES, INC. (US) 2022-03-03 — — WO disclosed
Send feedback